TB Regimen Could Pave Way For More FDA Involvement In Neglected Tropical Diseases

TB Alliance plans to seek FDA approval for its treatment regimen, which is beginning a Phase IIb trial, as the agency looks to respond to calls for a clearer and quicker pathway for NTD drugs.